U.S. NeuroSurgical Competitors and Similar CompaniesClear all

U.S. NeuroSurgical's competitors and similar companies include Medwell Ventures, IMAC Regeneration Centers, Respicardia and GAIA.
U.S. NeuroSurgical
U.S. NeuroSurgical
U.S. NeuroSurgical is a medical services company that partners with hospitals and physicians to own and operate facilities utilizing state-of-the-art and innovative technologies in medical treatment and/or diagnosis.
Medwell Ventures
Medwell Ventures
Medwell Ventures Leverages a powerful combination of Healthcare delivery expertise, smart technology and stringent processes, we make Healthcare more accessible, accountable, accurate, and personal.
IMAC Regeneration Centers
IMAC Regeneration Centers
IMAC Regeneration is a provider of nonsurgical treatments and therapies for soft tissue damage and neurological diseases.
Respicardia
Respicardia
Respicardia develops implantable therapies to improve respiratory and cardiovascular health.
GAIA
GAIA
GAIA specializes in digital therapeutics.
Founding Date
Founding Date
1993
Founding Date
2014
Founding Date
2000
Founding Date
2006
Founding Date
2001
Type
Type
Public
Type
Private
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Rockville, US HQ
Locations
Bengaluru, IN HQ
Locations
Paducah, US HQ
Bonita Springs, US
Brentwood, US
Chesterfield, US
Elgin, US
Lexington, US
Murray, US
see more
Locations
Hopkins, US HQ
Locations
Hamburg, DE HQ
Employees
Employees
3
Employees
552% decrease
Employees
105
Employees
94
Employees
5131% increase
Valuation ($)
Valuation ($)
9.4 m
Valuation ($)
N/A
Valuation ($)
2.1 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$1m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$72.1k (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$906k (FY, 2025)
Cost of goods
N/A
Cost of goods
$305.2k (FY, 2024)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$118k (FY, 2025)
Gross profit
N/A
Gross profit
($233.2k) (FY, 2024)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($7.8m) (FY, 2025)
Net income
N/A
Net income
($9m) (FY, 2024)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 41m
Total funding raised
N/A
Total funding raised
$ 149.1m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Medwell Ventures
HQ
Bengaluru, IN
Employees
55↓ 2% decrease

Medwell Ventures Leverages a powerful combination of Healthcare delivery expertise, smart technology and stringent processes, we make Healthcare more accessible, accountable, accurate, and personal.

View company
IMAC Regeneration Centers
HQ
Paducah, US
Employees
105

IMAC Regeneration is a provider of nonsurgical treatments and therapies for soft tissue damage and neurological diseases.

View company
Respicardia
HQ
Hopkins, US

Respicardia develops implantable therapies to improve respiratory and cardiovascular health.

View company
GAIA
HQ
Hamburg, DE
Employees
513↑ 1% increase

GAIA specializes in digital therapeutics.

View company